Pharma Mirror Magazine

  • Home
  • Articles
  • Global News
  • Interest
  • Global Events
    • Add Event
  • Health Tips
  • Knowledge
    • Drug Directory
    • Education
      • Pharmacy Case Study
      • Pharmacy eBook Reviews
    • Pharma Companies
    • Dictionary Online
    • Career
    • Pharma Video
    • Featured Pharma Leader
  • About
    • Contact Us
    • Write for Us
    • Privacy Policy

Mobile Logo

MORE NEWS

Manufacturers seeking CDMOs that can quickly develop complex formulations offering both body and mind benefits
Pharmaceutical News

COVID-19 winter lockdowns & national restrictions drive demand for ‘body and mind’ formulations say SIRIO Europe

December 14, 2020December 14, 2020

Manufacturers seeking CDMOs that can quickly develop complex formulations offering both body and mind benefits  SIRIO Europe (Ayanda) – the European nutraceutical

More
Telstar Bangladesh New Office
Pharmaceutical News

Telstar strengthens its activity in Bangladesh and relocates its office in Dhaka

December 10, 2020December 10, 2020

Terrassa (Barcelona) 2020. The Telstar subsidiary in Dhaka, Bangladesh, has relocated to a new installation reacting to the ongoing growth

More
CO2 Safety Monitors for Dry Ice Vaccination
Pharmaceutical News

CO2 Safety Monitors for Dry Ice Vaccination

December 9, 2020December 14, 2020

Ormond Beach, FL – CO2Meter, Inc. has partnered with a national pharmacy chain to keep their customers and employees safe

More
Pharma press releases
Pharmaceutical News

Vectura signs agreement to support the development of VR588 to treat asthma

December 1, 2020December 1, 2020

Chippenham, UK: Vectura Group plc, an industry leading inhalation CDMO, today announces that it has signed a global out licence

More
Pharma press releases
Pharmaceutical News

Vaccine nationalism, CDMO expansion, AMR and dual sourcing predicted in 2021

December 1, 2020December 1, 2020

The new report looks ahead to a post-pandemic 2021 with pharma manufacturing capacity and payment structures shifting as new sourcing

More
Catalent Signs Commercial Supply Agreement with Blueprint Medicines Following FDA Approval of GAVRETOT (pralsetinib)
Pharmaceutical News

Catalent Signs Commercial Supply Agreement with Blueprint Medicines Following FDA Approval of GAVRETO™ (pralsetinib)

November 24, 2020November 24, 2020

Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies,

More
Previous 1 2 3 4 … 48 Next

Subscribe

Subscribe our Articles, please enter your email below:

Please verify the email sent to your inbox to complete the subscription process. It's safe and free too.

Recent Posts

  • New Sales Directors at Romaco in Cologne, Bologna and Karlsruhe February 26, 2021
  • Catalent to Acquire Delphi Genetics and Launch US Plasmid Manufacturing Site February 24, 2021
  • The Wholesome Value of Holistic Wellness Treatments February 19, 2021
  • Maculus Therapeutix welcomes Privity FZ LLE and Prepares Capital Raise for Novel Drug Delivery Platform February 18, 2021
  • QS-21, the ‘Gold Standard’ of immune system activators used in Covid-19 and other vaccines to be presented by CEO Gaston Salinas at BIO CEO & Investor Conference February 18, 2021

Event Partnership

Purify India

© 2010-2020 PharmaMirror.com - All Rights Reserved.

  • Home
  • Articles
  • Global News
  • Interest
  • Global Events
    • Add Event
  • Health Tips
  • Knowledge
    • Drug Directory
    • Education
      • Pharmacy Case Study
      • Pharmacy eBook Reviews
    • Pharma Companies
    • Dictionary Online
    • Career
    • Pharma Video
    • Featured Pharma Leader
  • About
    • Contact Us
    • Write for Us
    • Privacy Policy
Go toTop